Clinical Trial Update: Augmented Macular Pigment-containing Nutraceutical and Central Visual Function [Phase 4]

View source ↗

Summary

Phase 4 trial investigating augmented macular pigment nutraceutical for glaucoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Glaucoma Open-angle

Snippet

Sponsor: University of the Incarnate Word | Conditions: Glaucoma, Glaucoma Eye | Phase 4 | Status: WITHDRAWN